Acute HCV/HIV Coinfection is Associated with Cognitive Dysfunction and Cerebral Metabolite Disturbance, but Not Increased Microglial Cell Activation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jul 19

PMID 22808022

Citations 20

Authors

Lucy J Garvey

Nicola Pavese

Anil Ramlackhansingh

Emma Thomson

Joanna M Allsop

Marios Politis

Ranjababu Kulasegaram

Janice Main

David J Brooks

Simon D Taylor-Robinson

Alan Winston

Affiliations

Soon will be listed here.

Abstract

Background: Microglial cell activation and cerebral function impairment are described in both chronic hepatitis C viral (HCV) and Human-Immune-Deficiency viral (HIV) infections. The aim of this study was to investigate the effect of acute HCV infection upon cerebral function and microglial cell activation in HIV-infected individuals.

Methods: A case-control study was conducted. Subjects with acute HCV and chronic HIV coinfection (aHCV) were compared to matched controls with chronic HIV monoinfection (HIVmono). aHCV was defined as a new positive plasma HCV RNA within 12 months of a negative RNA test. Subjects underwent neuro-cognitive testing (NCT), cerebral proton magnetic resonance spectroscopy ((1)H-MRS) and positron emission tomography (PET) using a (11)C-radiolabeled ligand (PK11195), which is highly specific for translocator protein 18 kDA receptors on activated microglial cells. Differences between cases and controls were assessed using linear regression modelling.

Results: Twenty-four aHCV cases completed NCT and (1)H-MRS, 8 underwent PET. Of 57 HIVmono controls completing NCT, 12 underwent (1)H-MRS and 8 PET. Subjects with aHCV demonstrated on NCT, significantly poorer executive function (mean (SD) error rate 26.50(17.87) versus 19.09(8.12), p = 0.001) and on (1)H-MRS increased myo-inositol/creatine ratios (mI/Cr, a marker of cerebral inflammation) in the basal ganglia (ratio of 0.71(0.22) versus 0.55(0.23), p = 0.03), compared to subjects with HIVmono. On PET imaging, no difference in (11)C-PK11195 binding potential (BP) was observed between study groups (p>0.10 all cerebral locations), however lower BPs were associated with combination antiretroviral therapy (cART) use in the parietal (p = 0.01) and frontal (p = 0.03) cerebral locations.

Discussion: Poorer cognitive performance and disturbance of cerebral metabolites are observed in subjects with aHC,V compared to subjects with HIVmono. Higher (11)C-PK11195 BP was not observed in subjects with aHCV, but was observed in subjects not on cART.

Citing Articles

PET imaging of neuroinflammation: any credible alternatives to TSPO yet?.

Chauveau F, Winkeler A, Chalon S, Boutin H, Becker G Mol Psychiatry. 2024; 30(1):213-228.

PMID: 38997465 DOI: 10.1038/s41380-024-02656-9.

Imaging of Brain Structural and Functional Effects in People With Human Immunodeficiency Virus.

OConnor E, Sullivan E, Chang L, Hammoud D, Wilson T, Ragin A J Infect Dis. 2023; 227(Suppl 1):S16-S29.

PMID: 36930637 PMC: 10022717. DOI: 10.1093/infdis/jiac387.

Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations.

Tagliapietra M, Monaco S Int J Mol Sci. 2020; 21(7).

PMID: 32252497 PMC: 7177498. DOI: 10.3390/ijms21072478.

Effects of comorbidity burden and age on brain integrity in HIV.

Saloner R, Heaton R, Campbell L, Chen A, Franklin Jr D, Ellis R AIDS. 2019; 33(7):1175-1185.

PMID: 30870195 PMC: 6613389. DOI: 10.1097/QAD.0000000000002192.

The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Zahr N Front Aging Neurosci. 2018; 10:56.

PMID: 29623036 PMC: 5874324. DOI: 10.3389/fnagi.2018.00056.

References

Forton D, Thomas H, Murphy C, Allsop J, Foster G, Main J . Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002; 35(2):433-9. DOI: 10.1053/jhep.2002.30688. View

Morgello S, Estanislao L, Ryan E, Gerits P, Simpson D, Verma S . Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS. 2005; 19 Suppl 3:S116-22. DOI: 10.1097/01.aids.0000192079.49185.f9. View

Brown A, Fujita M, Fujimura Y, Liow J, Stabin M, Ryu Y . Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med. 2007; 48(12):2072-9. DOI: 10.2967/jnumed.107.044842. View

Cagnin A, Taylor-Robinson S, Forton D, Banati R . In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut. 2005; 55(4):547-53. PMC: 1856189. DOI: 10.1136/gut.2005.075051. View

Christensen J, Kaufman M, Levin J, MENDELSON J, HOLMAN B, Cohen B . Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med. 1996; 35(5):658-63. DOI: 10.1002/mrm.1910350506. View

Browne R, Asboe D, Gilleece Y, Atkins M, Mandalia S, Gazzard B . Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?. Sex Transm Infect. 2004; 80(4):326-7. PMC: 1744861. DOI: 10.1136/sti.2003.008532. View

Grover V, Pavese N, Koh S, Wylezinska M, Saxby B, Gerhard A . Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 2012; 19(2):e89-96. DOI: 10.1111/j.1365-2893.2011.01510.x. View

Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A . In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis. 2005; 21(2):404-12. DOI: 10.1016/j.nbd.2005.08.002. View

Rojas S, Martin A, Arranz M, Pareto D, Purroy J, Verdaguer E . Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. 2007; 27(12):1975-86. DOI: 10.1038/sj.jcbfm.9600500. View

10.

Ridderinkhof K, Ullsperger M, Crone E, Nieuwenhuis S . The role of the medial frontal cortex in cognitive control. Science. 2004; 306(5695):443-7. DOI: 10.1126/science.1100301. View

11.

Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C . Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med. 2004; 51(5):904-12. DOI: 10.1002/mrm.20063. View

12.

Banati R, Newcombe J, Gunn R, Cagnin A, Turkheimer F, Heppner F . The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000; 123 ( Pt 11):2321-37. DOI: 10.1093/brain/123.11.2321. View

13.

Kim S, Kim I, Kim Y, Lee T, Lee J, Jun S . Probabilistic anatomic mapping of cerebral blood flow distribution of the middle cerebral artery. J Nucl Med. 2007; 49(1):39-43. DOI: 10.2967/jnumed.107.045724. View

14.

Ghosn J, Pierre-Francois S, Thibault V, Duvivier C, Tubiana R, Simon A . Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 2004; 5(4):303-6. DOI: 10.1111/j.1468-1293.2004.00225.x. View

15.

Hammoud D, Endres C, Chander A, Guilarte T, Wong D, Sacktor N . Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol. 2005; 11(4):346-55. DOI: 10.1080/13550280500187351. View

16.

Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M . Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002; 76(19):10064-8. PMC: 136534. DOI: 10.1128/jvi.76.19.10064-10068.2002. View

17.

Naressi A, Couturier C, Devos J, Janssen M, Mangeat C, de Beer R . Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001; 12(2-3):141-52. DOI: 10.1007/BF02668096. View

18.

Baltuch G . Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci. 1999; 22:219-40. DOI: 10.1146/annurev.neuro.22.1.219. View

19.

Haussinger D, Kircheis G, Fischer R, Schliess F, Vom Dahl S . Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol. 2000; 32(6):1035-8. DOI: 10.1016/s0168-8278(00)80110-5. View

20.

Letendre S, Cherner M, Ellis R, Marquie-Beck J, Gragg B, Marcotte T . The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005; 19 Suppl 3:S72-8. DOI: 10.1097/01.aids.0000192073.18691.ff. View